HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
NCT07049328 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-10-17
Summary
This is a Phase 1, open-label, multi-center, competitive enrollment, and dose-escalation study of HCW9302 in subjects with Alopecia Areata (AA)
Conditions
- Alopecia Areata(AA)
Interventions
- DRUG
-
HCW9302, an IL-2 fusion protein
Injection
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-16
- Primary Completion
- 2026-07-16
- Completion
- 2026-12-15
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
NCT02684123 ·Status: COMPLETED ·Phase: NA
-
Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
NCT00408798 ·Status: COMPLETED ·Phase: NA
-
Clinical Application of Stem Cell Educator Therapy in Alopecia Areata
NCT04011748 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
NCT03532958 ·Status: WITHDRAWN ·Phase: PHASE2
-
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
NCT02812342 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata
NCT02974868 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata
NCT01917058 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata
NCT05205070 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Alopecia Using Follicular Stem Cells
NCT05210452 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
NCT01950780 ·Status: COMPLETED ·Phase: PHASE2
-
Intralesional Cyclosporine for Alopecia Areata
NCT07029204 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Stem Cell Educator Therapy in Alopecia Areata
NCT01673789 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
NCT01840046 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
NCT07205159 ·Status: RECRUITING ·Phase: PHASE1
-
Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice
NCT00177099 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Crisaborole in Patients with Alopecia Areata
NCT04299503 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Phase II Study in Patients With Alopecia Areata
NCT04346316 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
NCT06340360 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings
NCT07200128 ·Status: COMPLETED
-
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
NCT04784533 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
NCT07029828 ·Status: RECRUITING ·Phase: PHASE3
-
Systemic Treatments for Alopecia Areata Registry
NCT06283316 ·Status: RECRUITING
-
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
NCT06501924 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
NCT02553330 ·Status: TERMINATED ·Phase: PHASE2
-
Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling
NCT04338295 ·Status: COMPLETED ·Phase: NA